broad oncology portfolio focused on expanding access to more affordable treatments for multiple types of cancer .”
Dr Arun Chandavarkar , CEO and Joint Managing Director , Biocon , said : “ We are extremely pleased with the regulatory progress of our biosimilars in the U . S . The FDA ’ s acceptance for review of our second BLA for a proposed biosimilar developed by Biocon and Mylan is an outcome of our strong R & D and manufacturing capabilities . Once approved , our proposed biosimilar pegfilgrastim
will provide a high quality alternative to branded pegfilgrastim ( Neulasta ®) for cancer patients during cytotoxic chemotherapy . It will expand our oncology portfolio and further enable us to fulfil our promise of making cancer-care affordable and accessible for patients across the globe .”
Govt extends Rotavirus vaccine immunization under UIP
“ It is our endeavour to protect each and every child in the country from vaccine preventable diseases . This is a new milestone towards expanding the coverage of full immunization in the country aimed at reducing child mortality ”, Mr J P Nadda , Union Minister for Health and Family Welfare stated this as he announced the expansion of the Rotavirus vaccine under its Universal Immunization Programme ( UIP ) in five additional states in function at Agartala .
“ This life-saving vaccine will not only improve the health of our children but will also reduce hospitalization and other conditions associated with diarrhoea due to Rotavirus such as malnutrition , delayed physical and mental development among children . Reduced hospitalization reduces the economic burden on the family and the health cost burden on the country ”, Mr Nadda said . He further stated that the Rotavirus vaccine
has been developed indigenously , under a public-private partnership by the Ministry of Science and Ministry of Health and Family Welfare . This , therefore , is a landmark achievement under ‘ Make in India ’ initiative , he stated .
The vaccine will prevent Rotavirus diarrhoea in children which accounts for approximately 40 per cent of hospitalizations from diarrhoea in India . Rotavirus diarrhoea is responsible for nearly 78,000 deaths , 32 lakh out-patient visits and nearly 9 lakh hospitalizations every year . Rotavirus diarrhoea can also lead to dehydration , malnutrition and delayed physical and mental development in children .
BIOVOICENEWS . COM 59